企業概要
Global Medical REIT Inc. operates as a net-lease medical real estate investment trust that acquires healthcare facilities and subsequently leases them to physician groups, as well as regional and national healthcare systems, generating steady rental income from long-term agreements. The company functions within the Real Estate sector, specifically in the REIT - Healthcare Facilities industry, a niche that provides essential infrastructure for medical practices while offering exposure to the growing demand for healthcare services. As of the latest data, the entity possesses a market capitalization of $979.78M, records annual revenue (TTM) of $144.83M, and employs a workforce of 26 individuals to manage its extensive portfolio. These valuation and revenue figures indicate that the company has established a significant presence in the specialized medical real estate market, commanding a substantial market cap relative to its reported annual sales, which suggests a high market multiple often associated with stable, income-generating assets in the healthcare infrastructure space.
財務健全性
The company reports revenue (TTM) of $144.83M with an EBITDA of $87.53M, yet it recorded a net income (TTM) of $-3,324,000, revealing a substantial gap where operating earnings are significantly diluted by interest expenses, depreciation, or other non-operating costs before reaching the bottom line. This disparity between EBITDA and net income highlights a capital-intensive structure where high fixed costs, primarily debt servicing, heavily impact the final profitability despite strong operational cash generation. The entity maintains a free cash flow of $66.02M, which demonstrates robust financial flexibility and the ability to service its obligations or fund operations without relying on external financing. Margins reflect this structural reality with a gross margin of 99.9%, indicating minimal cost of goods sold in a lease model, an operating margin of 24.5% showing effective control over operational expenses, and a profit margin of 1.7% which is compressed by the aforementioned financial costs. Liquidity and leverage are critical metrics here, with cash holdings of $14.59M standing against total debt of $723.14M, resulting in a debt-to-equity ratio of 142.96% that signifies a highly leveraged balance sheet typical for REITs but requiring careful monitoring of refinancing risks. Short-term liquidity appears sufficient given a current ratio of 1.91, suggesting the company holds more than double the current assets required to cover its current liabilities. However, the return on equity stands at a mere 0.4% while the return on assets is 1.7%, metrics that collectively reveal limited management effectiveness in generating substantial returns on the substantial capital base deployed to acquire these healthcare facilities.
バリュエーション評価
Valuation multiples present a complex picture, with a trailing P/E ratio listed as N/A due to the negative net income, while the forward P/E is quoted at 299.83, implying that the market prices in significant future earnings recovery or that current earnings are not yet reflective of the asset's value. The price-to-book ratio is 1.18, indicating that the stock trades at a slight premium over its net asset value, which is consistent with the income-generating nature of the underlying real estate assets. Alternative valuation metrics provide further context, including a price-to-sales ratio of 6.77 and an EV/EBITDA of 14.70, suggesting the market values the company's earnings power at a moderate multiple relative to enterprise value despite the negative reported earnings. Price action over the last year shows a 52-week high of $45.75 and a 52-week low of $29.05, meaning the current share price is trading within this established range and reflects market sentiment regarding the stability of the net-lease model. The stock exhibits a beta of 1.20, which indicates that the price volatility is higher than the broader market, suggesting that the stock will tend to move with greater magnitude than the overall market index during periods of equity market fluctuation.
Growth & Income
Revenue growth (YoY) stands at 8.6%, while earnings growth (YoY) is listed as N/A due to the current period's net loss, implying that top-line expansion is currently outpacing bottom-line profitability as the company navigates its high-debt structure. For dividend payers, the company offers a dividend yield of 8.3% with a payout ratio of 1114.3%, a figure that is mathematically unsustainable based on current net income and suggests the dividend is fully covered by operating cash flow rather than earnings, a common practice in leveraged REITs. Since the earnings growth metric is unavailable, the analysis focuses on the fact that the dividend is not supported by accrual accounting profits but rather by the strong free cash flow generation inherent to the net-lease business model. Overall, the company presents a profile characterized by moderate top-line growth supported by high cash yields, though investors must weigh the sustainability of the dividend against the highly leveraged balance sheet and the absence of positive reported earnings growth in the trailing twelve months.